Notice Pursuant to the National Cooperative Research and Production Act of 1993-Open Source Imaging Consortium, Inc., 14973 [2019-07255]

Download as PDF Federal Register / Vol. 84, No. 71 / Friday, April 12, 2019 / Notices Register pursuant to Section 6(b) of the Act on October 26, 2018 (83 FR 54142). Register pursuant to Section 6(b) of the Act on January 31, 2019 (84 FR 795). further the purposes and achieve the goals set forth above. Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–07256 Filed 4–11–19; 8:45 am] [FR Doc. 2019–07258 Filed 4–11–19; 8:45 am] [FR Doc. 2019–07255 Filed 4–11–19; 8:45 am] BILLING CODE 4410–11–P BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Antitrust Division Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Open Source Imaging Consortium, Inc. Notice Pursuant to the National Cooperative Research and Production Act of 1993—Silicon Integration Initiative, Inc. Notice is hereby given that, on March 20, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Open Source Imaging Consortium, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing (1) the identities of the parties to the venture and (2) the nature and objectives of the venture. The notifications were filed for the purpose of invoking the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Pursuant to Section 6(b) of the Act, the identities of the parties to the venture are: Boehringer Ingelheim USA Corporation, Ridgefield, CT; Three Lakes Partners, Northbrook, IL; Siemens Healthcare GmbH, Erlangen, GERMANY; and Fluidda NV, Groeningenlei, BELGIUM. The general area of Open Source Imaging Consortium, Inc.’s planned activity is to define digital imaging biomarkers for idiopathic pulmonary fibrosis and fibrotic interstitial lung diseases (the ‘‘Medical Conditions’’) in order to ensure accurate imaging-based diagnosis, prognosis and prediction of response to therapy, including: (a) Enabling the effective sharing, utilization, and analysis of data relating to the Medical Conditions;(b) establishing and sustaining Open Source Imaging Consortium, Inc. as the preferred data sharing and analytics platform for research relating to the Medical Conditions;(c) link academic, non-profit and corporate research communities for collaborative research facilitated by Open Source Imaging Consortium, Inc.;(d) align and grow a vibrant network of researchers and developers around the goals of Open Source Imaging Consortium, Inc.; and (e) undertaking such other activities as may from time to time be appropriate to Notice is hereby given that, on March 18, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Silicon Integration Initiative, Inc. (‘‘Si2’’) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Agile Analog LTD, Cambridgeshire, UNITED KINGDOM; Avatar Integrated Systems, Santa Clara, CA; Blue Cheetah Analog Design, Palo Alto, CA; Chengdu Higon IC Design Co., Ltd., Beijing, PEOPLE’S REPUBLIC OF CHINA; and D2S, Inc., San Jose, CA, have been added as parties to this venture. Also, Atoptech, Inc., Santa Clara, CA; Juniper Networks, San Diego, CA; D.E. Shaw Research, New York, NY; eASIC Corporation, Santa Clara, CA; EDXACT, Voiron, FRANCE; Fraunhofer Institute for Integrated Circuits IIS, Dresden, GERMANY; IC Manage, Inc., Campbell, CA; MINALOGIC, Grenoble, FRANCE; Oracle Corporation, Redwood City, CA; Peregrine Semiconductor Corporation, San Diego, CA; RICOH Electronic Devices Company, LTD, Tokyo, JAPAN; Sage Design Automation, Santa Clara, CA; and Teklatech A/S, Frederiksberg, DENMARK, have withdrawn as parties to this venture. In addition, the following member has changed its name: Thermo-Fisher Scientific, Inc. to Life Technologies Corporation, Carlsbad, CA. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Si2 intends to file additional written notifications disclosing all changes in membership. BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Advanced Media Workflow Association, Inc. jbell on DSK30RV082PROD with NOTICES 14973 Notice is hereby given that, on March 21, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Advanced Media Workflow Association, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Bridge Technologies Co AS, Oslo, NORWAY; TSL Products, Marlow, UNITED KINGDOM; and TAG Video Systems, Tel Aviv, ISRAEL, have been added as parties to this venture. Also, Korean Broadcasting System, Seoul, REPUBLIC OF KOREA; and Streampunk Media, Aultbea, UNITED KINGDOM, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and Advanced Media Workflow Association, Inc. intends to file additional written notifications disclosing all changes in membership. On March 28, 2000, Advanced Media Workflow Association, Inc. filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on March 28, 2000 (65 FR 40127). The last notification was filed with the Department on December 13, 2018. A notice was published in the Federal VerDate Sep<11>2014 18:18 Apr 11, 2019 Jkt 247001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\12APN1.SGM 12APN1

Agencies

[Federal Register Volume 84, Number 71 (Friday, April 12, 2019)]
[Notices]
[Page 14973]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-07255]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Open Source Imaging Consortium, Inc.

    Notice is hereby given that, on March 20, 2019, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Open Source Imaging Consortium, 
Inc. has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing (1) the identities 
of the parties to the venture and (2) the nature and objectives of the 
venture. The notifications were filed for the purpose of invoking the 
Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances.
    Pursuant to Section 6(b) of the Act, the identities of the parties 
to the venture are: Boehringer Ingelheim USA Corporation, Ridgefield, 
CT; Three Lakes Partners, Northbrook, IL; Siemens Healthcare GmbH, 
Erlangen, GERMANY; and Fluidda NV, Groeningenlei, BELGIUM. The general 
area of Open Source Imaging Consortium, Inc.'s planned activity is to 
define digital imaging biomarkers for idiopathic pulmonary fibrosis and 
fibrotic interstitial lung diseases (the ``Medical Conditions'') in 
order to ensure accurate imaging-based diagnosis, prognosis and 
prediction of response to therapy, including: (a) Enabling the 
effective sharing, utilization, and analysis of data relating to the 
Medical Conditions;(b) establishing and sustaining Open Source Imaging 
Consortium, Inc. as the preferred data sharing and analytics platform 
for research relating to the Medical Conditions;(c) link academic, non-
profit and corporate research communities for collaborative research 
facilitated by Open Source Imaging Consortium, Inc.;(d) align and grow 
a vibrant network of researchers and developers around the goals of 
Open Source Imaging Consortium, Inc.; and (e) undertaking such other 
activities as may from time to time be appropriate to further the 
purposes and achieve the goals set forth above.

Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-07255 Filed 4-11-19; 8:45 am]
 BILLING CODE 4410-11-P